Re-exposing Patients to Heparin After Heparin-Induced Thrombocytopenia – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Elizabeth B. Caudill et al., adding:
”Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
This single-center retrospective study followed 35 patients with prior heparin-induced thrombocytopenia who were re-exposed to heparin products.
Only one (2.9 percent) developed recurrent HIT, with no associated thrombosis, bleeding, or in-hospital mortality. Median interval from HIT diagnosis to re-exposure was 8.1 years, suggesting re-exposure may be safe in remote HIT.”
Title: Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
Authors: Elizabeth B. Caudill, Ju Hee Kim, Dareen M. Kanaan, Katelyn W. Sylvester, Liriany Y. Pimentel, Christine S. Kim, Jean M. Connors
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 7, 2026, 16:39Sara Lojo Lendoiro: When Thrombosis in Pregnancy Requires More Than One Specialty
-
Sep 7, 2026, 16:29King Harald V’s Illness and the Broader Clinical Burden of Autoimmune Hemolytic Anemia
-
Sep 7, 2026, 16:27Steffen Uffenorde: WHO Consolidated Guidelines for SCD in Children and Adolescents
-
Sep 7, 2026, 16:26Nikenza Viceconte: What If Years of Bleeding Symptoms Had an Underlying Genetic Cause?
-
Sep 7, 2026, 16:17Fitsum Negusse Assefa: Fascioliasis With Hepatic Hematoma and Extensive Venous Thrombosis
-
Sep 7, 2026, 15:58Samwel Mikaye: Deep Vein Thrombosis and What You Need to Know
-
Sep 7, 2026, 15:38Nikki Curtin: A Blood Donation is Life Saving for People Who Need It
-
Sep 7, 2026, 15:37Joseph Mmwa: WHO Unveils Regional Health Data Hub to Advance Data-Driven Health Decisions
-
Sep 7, 2026, 15:35Abdulaziz Hamoudi: The Multicenter Randomized PROTECT-EST Trial Reports Impressive Results for SAP